News | December 29, 2014

Clinical trial results are inconclusive to date while costs of PET/MRI are debated

Jury Still Out on Effectiveness of PET/MRI Versus PET/CT

December 29, 2014 — Manufacturers have introduced hybrid imaging systems that combine positron emission tomography (PET) with magnetic resonance imaging (MRI). The purported benefit is improved detail in organ and soft-tissue images without the ionizing radiation inherent with systems that combine PET with computed tomography (CT), the gold-standard hybrid imaging modality.

Utilization is affected by the uncertain reimbursement environment for integrated PET/MRI scans. Some private, third-party payers (Aetna, Anthem, Humana) deny coverage for the hybrid imaging exams. Clinical trials comparing PET/MRI to PET/CT imaging have generally not demonstrated a substantial difference in diagnostic accuracy between PET/MRI and PET/CT, affecting anticipated utilization.

ECRI Institute’s expert panel thought that the possible development of new PET radiotracers targeting brain structures and soft tissue tumors might increase PET/MRI utilization for certain indications, especially if evidence demonstrates a benefit in diagnostic accuracy and if reimbursement becomes available.

Potential Health Impact
Most clinical trials of PET/MRI underway are comparing it with PET/CT. Heusch et al. (2014) found no significant differences in tumor detection between the two modalities. Quick et al. (2013) reported that PET/MRI detected more tumors than PET/CT. However, other trials (Chandarana et al. 2013, Gaertner et al. 2013, Wiesmuller et al. 2013) found that PET/MRI detected most tumors identified by PET/CT. Afshar-Oromieh et al. (2014) and Beiderwellen et al. (2013) concluded that PET/MRI may have better contrast and tumor conspicuity than PET/CT, but Gaertner et al. (2013) found better tumor conspicuity with PET/CT.

Potential Financial Impact
Hospitals face substantial costs to acquire integrated PET/MRI technology, including construction or renovation required to accommodate the combined system’s physical requirements and to install MRI-compatible (nonmagnetic) ancillary medical equipment needed during imaging procedures. As changes in healthcare coverage place a greater financial burden on healthcare consumers, some patients may forgo expensive procedures or diagnostic tests, thereby reducing demand for some technologies.

For more information: www.ecri.org

Related Content

News | Contrast Media

June 23, 2022 — Supply chain disruptions have created critical shortages of Omnipaque (iohexol) and Visipaque (iodixanol ...

Time June 23, 2022
arrow
News | SNMMI

June 22, 2022 — The Society of Nuclear Medicine and Molecular Imaging recognized 15 new SNMMI Fellows on Monday, June 13 ...

Time June 22, 2022
arrow
News | SNMMI

June 22, 2022 — Andrei Iagaru, MD, FACNM, professor of radiology (nuclear medicine) and chief of the Division of Nuclear ...

Time June 22, 2022
arrow
News | PET Imaging

June 21, 2022 — Markus Schwaiger, MD, a scientist known for his contributions to cardiac PET imaging, has been named as ...

Time June 21, 2022
arrow
News | SNMMI

June 21, 2022 — Krystle W. Glasgow, MIS, CNMT, NMTCB(CT), NMAA, FSNMMI-TS, instructor and clinical coordinator at the ...

Time June 20, 2022
arrow
News | SNMMI

June 16, 2022 — Cathy Sue Cutler, PhD, FSNMMI, director of the medical isotope research and production program at ...

Time June 16, 2022
arrow
News | SPECT Imaging

June 15, 2022 — A cardiac SPECT imaging system performs scans 10 to 100 times faster than current SPECT systems ...

Time June 15, 2022
arrow
News | PET Imaging

June 15, 2022 — Poor functional outcomes after a heart attack can be predicted with a new PET imaging agent, 68Ga-FAPI ...

Time June 15, 2022
arrow
News | SNMMI

June 15, 2022 — Helen Nadel, MD, FRCPC, director of pediatric nuclear medicine at Lucile Packard Children’s Hospital at ...

Time June 15, 2022
arrow
News | PET-CT

June 14, 2022 — A novel artificial intelligence method can be used to generate high-quality “PET/CT” images and ...

Time June 14, 2022
arrow
Subscribe Now